Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 34,588,990 |
|
|||||
| News | - | ||||||
| Day High | 0.1895 | Low High |
|||||
| Day Low | 0.1585 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Jaguar Health Inc | JAGX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0004 | 0.24% | 0.1684 | 18:59:59 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.1752 | 0.1585 | 0.1895 | 0.1699 | 0.168 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 30,408 | 34,588,990 | US$ 0.1693231 | US$ 5,856,715 | - | 0.0512 - 1.22 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:59:59 | formt | 3,000 | US$ 0.1684 | USD |
Jaguar Health Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.63M | 50.76M | - | 9.76M | -41.3M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Jaguar Health News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/08/2024 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/05/2024 | 06:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
| 3/01/2024 | 16:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 15:13 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/01/2023 | 16:25 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/30/2023 | 07:10 | Edgar (US Regulatory) | Form D - Notice of Exempt Offering of Securities |
| 11/14/2023 | 20:00 | PR Newswire (Canada) | FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2023 FINANCIAL.. |
| 11/08/2023 | 16:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/05/2023 | 16:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/21/2023 | 06:30 | PR Newswire (Canada) | FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA.. |
| 8/14/2023 | 15:55 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/14/2023 | 15:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical JAGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.1852 | 0.2089 | 0.1423 | 0.1709554 | 75,829,978 | -0.0168 | -9.07% |
| 1 Month | 0.071 | 0.254 | 0.0687 | 0.1420916 | 86,494,104 | 0.0974 | 137.18% |
| 3 Months | 0.1101 | 0.254 | 0.0512 | 0.1165604 | 61,353,582 | 0.0583 | 52.95% |
| 6 Months | 0.30 | 0.5144 | 0.0512 | 0.1248995 | 32,837,213 | -0.1316 | -43.87% |
| 1 Year | 0.56 | 1.22 | 0.0512 | 0.1592501 | 17,936,232 | -0.3916 | -69.93% |
| 3 Years | 120.75 | 228.00 | 0.0512 | 21.87 | 8,999,245 | -120.58 | -99.86% |
| 5 Years | 1,275.75 | 1,391.25 | 0.0512 | 77.43 | 9,831,958 | -1,275.58 | -99.99% |
Jaguar Health Description
| Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. |
